Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids
Mechanisms of Ageing and Development · 2025-02 · 223 · 112007
DOI: 10.1016/j.mad.2024.112007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mechanisms of Ageing and Development, 2025-02. Verfasst von Mariangela Scalise und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro 88100, Italy; Centre for Human and Applied Physiological, Schoo…. Hauptthemen laut MEDLINE: Organoids, Cardiomyopathies, Senotherapeutics, Myocytes, Cardiac. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King's College London, Ministero dell’Istruzione, dell’Università e della Ricerca, Ministero della Salute.
Abstract (Originalsprache)
BACKGROUND: Human cardiac organoids closely replicate the architecture and function of the human heart, offering a potential accurate platform for studying cellular and molecular features of aging cardiomyopathy. Senolytics have shown potential in addressing age-related pathologies but their potential to reverse aging-related human cardiomyopathy remains largely unexplored. METHODS: We employed human iPSC-derived cardiac organoids (hCOs/hCardioids) to model doxorubicin(DOXO)-induced cardiomyopathy in an aged context. hCardioids were treated with DOXO and subsequently with a combination of two senolytics: dasatinib (D) and quercetin (Q). RESULTS: DOXO-treated hCardioids exhibited significantly increased oxidative stress, DNA damage (pH2AX), cellular senescence (p16INK4A) and decreased cell proliferation associated with a senescence-associated secretory phenotype (SASP). DOXO-treated hCardioids were considerably deprived of cardiac progenitors and displayed reduced cardiomyocyte proliferation as well as contractility. These distinctive aging-associated characteristics were confirmed by global RNA-sequencing analysis. Treatment with D+Q reversed these effects, reducing oxidative stress and senescence markers, alleviating SASP, and restoring hCardioids viability and function. Additionally, senolytics replenished cardiac progenitors and reversed the cardiomyocyte proliferation deficit. CONCLUSIONS: Doxorubicin triggers an age-associated phenotype in hCardioids reliably modelling the main cellular and molecular features of aging cardiomyopathy. Senescence is a key mechanism of the aged-hCOs phenotype as senolytics rejuvenated aged-hCardioids restoring their structure and function while reverting the age-associated regenerative deficit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro 88100, Italy; Centre for Human and Applied Physiological, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medic…
- Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro 88100, Italy. Electronic address: cianflone@unicz.it.
- Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro 88100, Italy.
- Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro 88100, Italy.
- Department of Experimental Medicine, University of Campania "L. Vanvitelli", Naples 80138, Italy.
- DIMES Department of Informatics, Modeling, Electronics and Systems, UNICAL, Rende, Cosenza, Italy.
Förderung
- King's College London
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Ministero della Salute
Zitieren
APA
Scalise, M., Cianflone, E., Quercia, C., Pagano, L., Chiefalo, A., Stincelli, A., Torella, A., Puccio, B., Santamaria, G., Guzzi, H. P., Veltri, P., De Angelis, A., Urbanek, K., Ellison-Hughes, G. M., Torella, D., & Marino, F. (2025). Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids. Mechanisms of Ageing and Development, 223, 112007. https://doi.org/10.1016/j.mad.2024.112007
Vancouver
Scalise M, Cianflone E, Quercia C, Pagano L, Chiefalo A, Stincelli A, et al. Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids. Mechanisms of Ageing and Development. 2025;223:112007. doi:10.1016/j.mad.2024.112007
BibTeX
@article{Scalise2025,
author = {Scalise, Mariangela and Cianflone, Eleonora and Quercia, Claudia and Pagano, Loredana and Chiefalo, Antonio and Stincelli, Antonio and Torella, Annalaura and Puccio, Barbara and Santamaria, Gianluca and Guzzi, Hiram P and Veltri, Pierangelo and De Angelis, Antonella and Urbanek, Konrad and Ellison-Hughes, Georgina M and Torella, Daniele and Marino, Fabiola},
title = {Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids},
journal = {Mechanisms of Ageing and Development},
year = {2025},
volume = {223},
pages = {112007},
doi = {10.1016/j.mad.2024.112007}
}
EUVIMED